The H2304E1 Study: Efficacy and Safety of Everolimus With Reduced Tacrolimus Versus Standard Tacrolimus in De Novo Liver Transplant Recipients at 36 Months.

被引：0

作者：

De Simone, P. ^{[1
]}

Kaiser, G. M. ^{[1
]}

De Carlis, L. ^{[1
]}

Metselaar, H. J. ^{[1
]}

Duvoux, C. ^{[1
]}

Nevens, F. ^{[1
]}

Fischer, L. ^{[1
]}

Fung, J. ^{[1
]}

Dong, G. ^{[1
]}

Rauer, B. ^{[1
]}

Junge, G. ^{[1
]}

Saliba, F. ^{[1
]}

机构：

[1] H2304E1 Study Grp, Pisa, Italy

来源：

LIVER TRANSPLANTATION | 2014年 / 20卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

O-10

引用

页码：S106 / S106

页数：1

共 50 条

[31] Design and Baseline Data from Hephaistos Study Evaluating Efficacy and Safety of Early Initiation of Everolimus With Reduced Tacrolimus in De Novo Liver Transplant Recipients
Nashan, Bjorn
Schemmer, Peter
Braun, Felix
Dworak, Markus
Wimmer, Peter
Schlitt, Hans
TRANSPLANTATION, 2015, 99 : 214 - 215
[32] mTOR Inhibitor Attributed Adverse Events: Results from the H2304 Study Comparing Everolimus and Tacrolimus in De Novo Liver Transplant Recipients
Fischer, L.
De Simone, P.
Fung, J.
Nevens, F.
Metselaar, H. J.
Beckebaum, S.
Saliba, F.
Jonas, S.
Sudan, D.
Chavin, K.
Chapman, W. C.
Jiang, H.
Lopez, P.
Junge, G.
De Carlis, L.
AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 126 - 126
[33] The Athena Study: 12 Months Safety and Efficacy Data for Everolimus Combined with Tacrolimus or Cyclosporine Compared to a Standard Tacrolimus-Mycophenolate Regimen in de Novo Kidney Transplant Patients
Nashan, Bjoern
Sommerer, Claudia
Suwelack, Barbara
Dragun, Duska
Hauser, Ingeborg A.
Witzke, Oliver
Hugo, Christian
Kamar, Nassim
Merville, Pierre
Schenker, Peter
Junge, Martina
Thaiss, Friedrich
TRANSPLANTATION, 2018, 102 : S279 - S279
[34] Superior Renal Function Sustained for 24 Months through Early Everolimus-Facilitated Reduction of Tacrolimus Versus Standard Tacrolimus in De Novo Liver Transplant Recipients: Results of a Randomized Trial
De Simone, P.
Detry, O.
Kintmalm, G.
Goss, J.
McCormick, P.
Rossi, M.
Moya, A.
Lopez, P.
Junge, G.
Dong, G.
Joseph, D.
Duvoux, C.
AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 169 - 170
[35] The safety and efficacy of sirolimus and low-dose tacrolimus versus tacrolimus in de novo orthotopic liver transplant recipients: Results from a pilot study.
Wiesner, R
HEPATOLOGY, 2002, 36 (04) : 208A - 208A
[36] Everolimus With Reduced Tacrolimus Improves Renal Function in De Novo Liver Transplant Recipients: A Randomized Controlled Trial
De Simone, P.
Nevens, F.
De Carlis, L.
Metselaar, H. J.
Beckebaum, S.
Saliba, F.
Jonas, S.
Sudan, D.
Fung, J.
Fischer, L.
Duvoux, C.
Chavin, K. D.
Koneru, B.
Huang, M. A.
Chapman, W. C.
Foltys, D.
Witte, S.
Jiang, H.
Hexham, J. M.
Junge, G.
AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (11) : 3008 - 3020
[37] Exposure-Response Analysis of Everolimus and Tacrolimus in De Novo Liver Transplant Recipients: 24-Month Results from the H2304 Study.
Fischer, L.
Kaiser, G. M.
Huang, M. A.
Toselli, L.
Durand, F.
Heaton, N.
Shetty, K.
Klintmalm, G.
Dong, G.
Lopez, P.
Junge, G.
Kovarik, J. M.
LIVER TRANSPLANTATION, 2013, 19 : S148 - S148
[38] Everolimus in De Novo Liver Transplant Recipients To Either Minimize or Eliminate Tacrolimus - Study Design and Update
Filipponi, F.
De Carlis, L.
Metselaar, H. J.
Nevens, F.
Saliba, F.
Junge, G.
LIVER TRANSPLANTATION, 2010, 16 (06) : S132 - S133
[39] Efficacy and safety of cyclosporine microemulsion with C2 monitoring versus tacrolimus in de novo liver transplant recipients
Villamill, F
Ericzon, BG
Risaliti, A
Munn, S
Cantisani, G
Jones, R
Rossi, M
Klintmalm, G
Levy, G
LIVER TRANSPLANTATION, 2003, 9 (06) : C79 - C79
[40] The safety and efficacy of sirolimus and cyclosporine versus tacrolimus in de novo orthotopic liver transplant recipients: Results from a pilot study.
Wiesner, RH
HEPATOLOGY, 2001, 34 (04) : 254A - 254A

← 1 2 3 4 5 →